BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zanetto A, Campello E, Spiezia L, Burra P, Simioni P, Russo FP. Cancer-Associated Thrombosis in Cirrhotic Patients with Hepatocellular Carcinoma. Cancers (Basel). 2018;10. [PMID: 30453547 DOI: 10.3390/cancers10110450] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 6.8] [Reference Citation Analysis]
Number Citing Articles
1 Noumegni SR, Didier R, Mansourati V, Tromeur C, Le Moigne E, Hoffmann C, Nasr B, Gentric J, Guegan M, Poulhazan E, Lacut K, Bressollette L, Le Mao R, Couturaud F. Risk factors of arterial thrombotic events after unprovoked venous thromboembolism, and after cancer associated venous thromboembolism: A prospective cohort study. Thrombosis Research 2022. [DOI: 10.1016/j.thromres.2022.04.016] [Reference Citation Analysis]
2 Faccia M, Santopaolo F, Gasbarrini A, Pompili M, Zocco MA, Ponziani FR. Risk factors for portal vein thrombosis or venous thromboembolism in a large cohort of hospitalized cirrhotic patients. Intern Emerg Med. [DOI: 10.1007/s11739-022-02928-8] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Zanetto A, Campello E, Bulato C, Gavasso S, Saggiorato G, Shalaby S, Spiezia L, Cillo U, Farinati F, Russo FP, Burra P, Senzolo M, Simioni P. More Pronounced Hypercoagulable State and Hypofibrinolysis in Patients With Cirrhosis With Versus Without HCC. Hepatol Commun 2021;5:1987-2000. [PMID: 34558850 DOI: 10.1002/hep4.1781] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
4 Tuck N, Kamran S. Inferior Vena Cava Tumor Thrombus Secondary to Mucinous Adenocarcinoma of the Stomach. Cureus 2021;13:e16543. [PMID: 34466306 DOI: 10.7759/cureus.16543] [Reference Citation Analysis]
5 Zhang XP, Zhou TF, Feng JK, Sun ZY, Zhen ZJ, Zhou D, Zhang F, Hu YR, Zhong CQ, Chen ZH, Chai ZT, Wang K, Shi J, Guo WX, Wu MC, Lau WY, Cheng SQ. Association of Preoperative Coagulability With Incidence and Extent of Portal Vein Tumor Thrombus and Survival Outcomes in Hepatocellular Carcinoma After Hepatectomy: A Large-Scale, Multicenter Study. Front Oncol 2021;11:697073. [PMID: 34395264 DOI: 10.3389/fonc.2021.697073] [Reference Citation Analysis]
6 Tan RZH, Lockart I, Abdel Shaheed C, Danta M. Systematic review with meta-analysis: The effects of non-steroidal anti-inflammatory drugs and anti-platelet therapy on the incidence and recurrence of hepatocellular carcinoma. Aliment Pharmacol Ther 2021;54:356-67. [PMID: 34247393 DOI: 10.1111/apt.16515] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
7 Rangaswamy C, Mailer RK, Englert H, Konrath S, Renné T. The contact system in liver injury. Semin Immunopathol 2021. [PMID: 34125270 DOI: 10.1007/s00281-021-00876-7] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
8 Hsu JY, Liu PP, Liu AB, Huang HK, Loh CH. High 1-year risk of stroke in patients with hepatocellular carcinoma: a nationwide registry-based cohort study. Sci Rep 2021;11:10444. [PMID: 34001950 DOI: 10.1038/s41598-021-89867-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Ma Y, Li G, Li X, Gao Y, Ding T, Yang G, Zhang Y, Nian J, Yu M, Wang X. Clinical characteristics and prognostic analysis of Lung Cancer patients with Hypercoagulability: A single-center, retrospective, real-world study. J Cancer 2021;12:2968-74. [PMID: 33854597 DOI: 10.7150/jca.46600] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Ding J, Hostallero DE, El Khili MR, Fonseca GJ, Milette S, Noorah N, Guay-Belzile M, Spicer J, Daneshtalab N, Sirois M, Tremblay K, Emad A, Rousseau S. A network-informed analysis of SARS-CoV-2 and hemophagocytic lymphohistiocytosis genes' interactions points to Neutrophil extracellular traps as mediators of thrombosis in COVID-19. PLoS Comput Biol 2021;17:e1008810. [PMID: 33684134 DOI: 10.1371/journal.pcbi.1008810] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
11 Violi F, Loffredo L, Pastori D. Anticoagulation in patients with advanced liver disease: an open issue. Intern Emerg Med 2021;16:61-71. [PMID: 33073317 DOI: 10.1007/s11739-020-02526-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Yao B, Niu Y, Li Y, Chen T, Wei X, Liu Q. High-matrix-stiffness induces promotion of hepatocellular carcinoma proliferation and suppression of apoptosis via miR-3682-3p-PHLDA1-FAS pathway. J Cancer 2020;11:6188-203. [PMID: 33033502 DOI: 10.7150/jca.45998] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
13 Serag WM, Mohammed BSE, Mohamed MM, Elsayed BE. Predicting the risk of portal vein thrombosis in patients with liver cirrhosis and hepatocellular carcinoma. Heliyon 2020;6:e04677. [PMID: 32904199 DOI: 10.1016/j.heliyon.2020.e04677] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
14 Thietart S, Rautou PE. Extracellular vesicles as biomarkers in liver diseases: A clinician's point of view. J Hepatol 2020;73:1507-25. [PMID: 32682050 DOI: 10.1016/j.jhep.2020.07.014] [Cited by in Crossref: 12] [Cited by in F6Publishing: 41] [Article Influence: 6.0] [Reference Citation Analysis]
15 Shalaby S, Simioni P, Campello E, Spiezia L, Gavasso S, Bizzaro D, Cardin R, D'amico F, Gringeri E, Cillo U, Barbiero G, Battistel M, Zanetto A, Ruzzarin A, Burra P, Senzolo M. Endothelial Damage of the Portal Vein is Associated with Heparin-Like Effect in Advanced Stages of Cirrhosis. Thromb Haemost 2020;120:1173-81. [DOI: 10.1055/s-0040-1713169] [Cited by in Crossref: 10] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
16 Yao B, Li Y, Niu Y, Wang L, Chen T, Guo C, Liu Q. Hypoxia-induced miR-3677-3p promotes the proliferation, migration and invasion of hepatocellular carcinoma cells by suppressing SIRT5. J Cell Mol Med 2020;24:8718-31. [PMID: 32596968 DOI: 10.1111/jcmm.15503] [Cited by in Crossref: 5] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
17 Facciorusso A, Bargellini I, Cela M, Cincione I, Sacco R. Comparison between Y90 Radioembolization Plus Sorafenib and Y90 Radioembolization alone in the Treatment of Hepatocellular Carcinoma: A Propensity Score Analysis. Cancers (Basel) 2020;12:E897. [PMID: 32272656 DOI: 10.3390/cancers12040897] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
18 Alkhouri N, Imawari M, Izumi N, Osaki Y, Ochiai T, Kano T, Bentley R, Trevisani F. Lusutrombopag Is Safe and Efficacious for Treatment of Thrombocytopenia in Patients With and Without Hepatocellular Carcinoma. Clin Gastroenterol Hepatol 2020;18:2600-2608.e1. [PMID: 32205226 DOI: 10.1016/j.cgh.2020.03.032] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
19 Zhang X, Wang T, Zhang KH, Chen SH, He YT, Wang YQ. Simple Clinical Metrics Enhance AFP to Effectively Identify Cirrhotic Patients With Complicating Hepatocellular Carcinoma at Various AFP Levels. Front Oncol 2019;9:1478. [PMID: 32038998 DOI: 10.3389/fonc.2019.01478] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
20 Zhang XP, Cheng SQ. ASO Author Reflections: Preoperative Hypercoagulability Predicts Poor Prognosis in Hepatocellular Carcinoma Patients with Microvascular Invasion After Hepatectomy. Ann Surg Oncol 2019;26:806-7. [PMID: 31654157 DOI: 10.1245/s10434-019-07986-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Campello E, Radu CM, Zanetto A, Bulato C, Shalaby S, Spiezia L, Franceschet E, Burra P, Russo FP, Simioni P. Changes in plasma circulating microvesicles in patients with HCV-related cirrhosis after treatment with direct-acting antivirals. Liver Int 2020;40:913-20. [PMID: 31454463 DOI: 10.1111/liv.14234] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
22 Pascual S, Miralles C, Bernabé JM, Irurzun J, Planells M. Surveillance and diagnosis of hepatocellular carcinoma: A systematic review. World J Clin Cases 2019; 7(16): 2269-2286 [PMID: 31531321 DOI: 10.12998/wjcc.v7.i16.2269] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
23 Faccia M, Ainora ME, Ponziani FR, Riccardi L, Garcovich M, Gasbarrini A, Pompili M, Zocco MA. Portal vein thrombosis in cirrhosis: Why a well-known complication is still matter of debate. World J Gastroenterol 2019; 25(31): 4437-4451 [PMID: 31496623 DOI: 10.3748/wjg.v25.i31.4437] [Cited by in CrossRef: 32] [Cited by in F6Publishing: 25] [Article Influence: 10.7] [Reference Citation Analysis]
24 Pavlovic N, Rani B, Gerwins P, Heindryckx F. Platelets as Key Factors in Hepatocellular Carcinoma. Cancers (Basel) 2019;11:E1022. [PMID: 31330817 DOI: 10.3390/cancers11071022] [Cited by in Crossref: 19] [Cited by in F6Publishing: 27] [Article Influence: 6.3] [Reference Citation Analysis]
25 Zhang X, Zhou T, Wang Z, Zhang F, Zhong C, Hu Y, Wang K, Chai Z, Chen Z, Wu M, Lau WY, Cheng S. Association of Preoperative Hypercoagulability with Poor Prognosis in Hepatocellular Carcinoma Patients with Microvascular Invasion After Liver Resection: A Multicenter Study. Ann Surg Oncol 2019;26:4117-25. [DOI: 10.1245/s10434-019-07504-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
26 Geng YD, Chen YR, Jin J, Wang XD, Zhang S, Li DJ. Prognostic Value of D-Dimer in Patients with Diffuse Large B-cell Lymphoma: A Retrospective Study. Curr Med Sci 2019;39:222-7. [PMID: 31016514 DOI: 10.1007/s11596-019-2023-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
27 Metharom P, Falasca M, Berndt MC. The History of Armand Trousseau and Cancer-Associated Thrombosis. Cancers (Basel) 2019;11:E158. [PMID: 30708967 DOI: 10.3390/cancers11020158] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 5.7] [Reference Citation Analysis]